Saving this dinosaur took a skeleton crew









The urgent message went well beyond Robert Painter's usual areas of legal expertise — personal injury, commercial disputes, medical malpractice.


In less than 48 hours, the skeleton of a Tyrannosaurus bataar, a fierce cousin of Tyrannosaurus rex, would be up for auction.


"Sorry for the late notice," the email said. "Is there anything we can do to legally stop this?"





The president of Mongolia, whom Painter had met 10 years before at a public policy conference, was now asking the Houston lawyer to block the sale of a fossil that scientists believed had been looted from the Gobi Desert. The auction catalog described the specimen:


"The quality of the preservation is superb, with wonderful bone texture and delightfully mottled grayish bone color. In striking contrast are those deadly teeth, long and frightfully robust, in a warm woody brown color, the fearsome, bristling mouth and monstrous jaws leaving one in no doubt as to how the creature came to rule its food chain."


The sheer size and condition of the fossil seemed guaranteed to fetch a seven-figure price. When Painter read the email May 18, it was already 6:30 p.m. on a Friday. The auction was Sunday.


In the days that followed, Painter, a New York auctioneer, a Texas judge, federal prosecutors, the Mongolian president and a self-described "commercial paleontologist" would come together somewhat like the skeleton they were fighting for, disparate parts brought together through dogged effort and mysterious circumstances.


The fight would play out in federal courts in a case known as United States of America vs. One Tyrannosaurus Bataar Skeleton.


***


Since 1924, the Mongolian constitution has classified dinosaur fossils as "culturally significant," meaning they cannot be taken from the country without government permission. Over the years, the punishment for illegally keeping or smuggling dinosaur bones has varied from up to seven years in prison to 500 hours of forced labor or paying up to 500,000 tugriks, the Mongolian currency. (That's about $356.50.)


Cultural heritage is a sensitive subject for a people who, their history of Genghis Khan's empire-building notwithstanding, saw powerful, aggressive neighbors invade their lands repeatedly.


After advertising for the auction caught the attention of paleontologists worldwide, Mongolian officials and journalists quickly learned of the fossil with the "delightfully mottled grayish bone color."


"The dinosaur has the color of the Gobi sand," said Oyungerel Tsedevdamba, an advisor to Mongolian President Tsakhiagiin Elbegdorj. "Such color is very particular and familiar to us and belongs to this country."


On May 18, as Tsedevdamba was preparing to leave her home in the Mongolian capital, Ulan Bator, for a meeting, her husband, a science enthusiast, pointed out a news report he'd found online: A Tyrannosaurus bataar was going to be auctioned in New York.


Auctioned fossils are usually too expensive for universities to buy, and private sellers typically don't provide enough details on how or where they got them. That leaves many of the bones in the hands of wealthy fossil buffs, or museums that look the other way.


"Technically, public institutions are neither ethically allowed to own poached specimens, nor are scientists supposed to publish on poached specimens," said Philip Currie, a University of Alberta paleontologist who studied the Gobi Desert region for 15 years. "In other words, they become scientifically useless."


The Tyrannosaurus bataar was 24 feet long, stood 8 feet high and weighed two tons. Still, the beast was only two-thirds grown when it died 70 million years ago.


Though it never grew into a 34-foot adult, the Tyrannosaurus thrived on the abundant prey attracted to the Nemegt Basin, then a lush river plain that straddled what is today the Gobi Desert on the Mongolia-China border. The carnivore's main competitors were its own kind.


The creature's jaw still carries bite marks, apparently inflicted by another Tyrannosaurus bataar.


These predators were "scrappy," Currie said. "They weren't overly playful."





Read More..

A Google-a-Day Puzzle for Jan. 15











Our good friends at Google run a daily puzzle challenge and asked us to help get them out to the geeky masses. Each day’s puzzle will task your googling skills a little more, leading you to Google mastery. Each morning at 12:01 a.m. Eastern time you’ll see a new puzzle posted here.


SPOILER WARNING:
We leave the comments on so people can work together to find the answer. As such, if you want to figure it out all by yourself, DON’T READ THE COMMENTS!


Also, with the knowledge that because others may publish their answers before you do, if you want to be able to search for information without accidentally seeing the answer somewhere, you can use the Google-a-Day site’s search tool, which will automatically filter out published answers, to give you a spoiler-free experience.


And now, without further ado, we give you…


TODAY’S PUZZLE:



Note: Ad-blocking software may prevent display of the puzzle widget.




Ken is a husband and father from the San Francisco Bay Area, where he works as a civil engineer. He also wrote the NYT bestselling book "Geek Dad: Awesomely Geeky Projects for Dads and Kids to Share."

Read more by Ken Denmead

Follow @fitzwillie and @wiredgeekdad on Twitter.



Read More..

Disney drops “Little Mermaid” re-release as 3D sales disappoint






(Reuters) – Walt Disney canceled plans for a 3D version of its 1989 animated hit “The Little Mermaid” after disappointing re-releases of “Monsters, Inc” and “Beauty and the Beast” in the format.


The film was the last of four releases for which Disney announced plans to convert some of its animated films after “The Lion King” generated domestic ticket sales of $ 94 million in 2011. “Monsters, Inc, its most recent film converted to 3D, had domestic ticket sales of only $ 30.6 million, according to the site Box Office Mojo.






Disney began 3D conversion of the underwater animated film in November, animated studio chief John Lasseter, said in interviews in November. Conversion of existing films to 3D are considered generally inexpensive and are viewed by Disney as generating publicity to boost the DVD sales of older films.


Disney said will release a fifth “Pirates of the Caribbean” movie on July 10, 2015, the studio said in an email announcing its revised release schedule.


The company said it would release two of its Marvel big-budget films in 3D next year: “Captain America: The Winter Soldier” and “Guardians of the Galaxy.”


(Reporting By Ronald Grover. Editing by Andre Grenon)


Movies News Headlines – Yahoo! News





Title Post: Disney drops “Little Mermaid” re-release as 3D sales disappoint
Url Post: http://www.news.fluser.com/disney-drops-little-mermaid-re-release-as-3d-sales-disappoint/
Link To Post : Disney drops “Little Mermaid” re-release as 3D sales disappoint
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Well: Turning to the Web for a Medical Diagnosis

Thirty-five percent of American adults said they have used the Internet to diagnose a medical condition for themselves or someone else, according to a new Pew Research Center study. Women are more likely than men to turn to the Internet for diagnoses. Other groups more likely to do so are younger people, white adults, people with college degrees and those who live in households with income above $75,000.

The study, released by Pew’s Internet and American Life Project on Tuesday, points out that Americans have always tried to answer their health questions at home, but that the Internet has expanded the options for research. Previous surveys have asked questions about online diagnoses, but the Pew study was the first to focus on the topic with a nationally representative sample, said Susannah Fox, an associate director at Pew Internet. Surveyors interviewed 3,014 American adults by telephone, from August to September 2012.

Of the one in three Americans who used the Internet for a diagnosis, about a third said they did not go to a doctor to get a professional medical opinion, while 41 percent said a doctor confirmed their diagnosis. Eighteen percent said a doctor did not agree with their diagnosis. As far as where people start when researching health conditions online, 77 percent said they started at a search engine like Google, Bing or Yahoo, while 13 percent said they began at a site that specializes in health information.

Read More..

Roche Hires Dr. John Reed to Lead Research Operations





The Swiss pharmaceutical giant Roche is turning to a prolific American academic scientist to revitalize its lagging research operations.




Dr. John C. Reed, the chief executive of the Sanford-Burnham Medical Research Institute in San Diego, will become head of Roche’s pharmaceutical research and early development group in April, the company announced Tuesday.


Dr. Reed, 54, has spent 21 years at Sanford-Burnham, formerly known as the Burnham Institute, the last 11 as chief executive.


During his tenure as chief executive, the institute grew rapidly, opened a new research site in Florida, and broadened its role from basic research to also doing drug discovery, in some cases in collaborations with pharmaceutical companies. It also received its largest donation ever, $50 million, from the credit card industry executive T. Denny Sanford, which led the institute to change its name.


Dr. Reed, 54, who holds both a medical degree and a Ph.D., is the author of more than 800 scientific papers, many dealing with why cancer cells do not commit suicide as errant cells are supposed to do. A triathlete, Dr. Reed used to get to his office around 3:30 a.m. each day, though now, with better computers, he works at home in the early hours.


“With his broad scientific and medical background, he is ideally positioned to drive Roche’s strategy of translating a better understanding of disease mechanisms into promising therapeutics,” Severin Schwan, the chief of Roche, said in a statement.


It is not unprecedented for drug companies to tap academic scientists to run research. Sanofi’s research and development is now run by Elias Zerhouni, the former director of the National Institutes of Health and professor at Johns Hopkins. Mark Fishman, a cardiologist at Harvard, was recruited to run research at Novartis, and Peter S. Kim, who heads research at Merck, was previously a biology professor at the Massachusetts Institute of Technology.


Dr. Reed, who has been on biotechnology company boards but never had a full-time corporate job, said in an interview that he was joining Roche to “have an opportunity to contribute on a larger stage, so to speak.”


At Roche he will oversee not only research but also early- and middle-stage clinical trials, something Sanford-Burnham does not do. He will supervise about 2,000 people with an annual budget in the billions, while Sanford-Burnham has about 1,200 people and a budget of around $175 million.


Dr. Reed, who will move to Basel, where Roche is based, said it was too early to discuss his agenda at Roche, other than to make its research more collaborative.


The operation Dr. Reed will run, called Pharma Research and Early Development, or pRED, does not include Genentech, the California biotechnology company that Roche fully acquired in 2009. In an effort to preserve the culture at Genentech, Roche left it autonomous, forming a group it calls gRED.


Recently, gRED has been eclipsing pRED. Roche’s three best-selling drugs, the cancer medicines Rituxan, Herceptin and Avastin, were developed at Genentech. So have some of its most attractive experimental drugs, including T-DM1, a breast cancer drug that could win regulatory approval early this year.


The organization Dr. Reed will run, by contrast, has had its share of problems in recent years. Several hundred researchers were cut in a corporate reorganization. And last year Roche discontinued development of a heart drug after it failed to work in a late-stage clinical trial.


The troubles contributed to Roche’s decision in June to shut its campus in Nutley, N.J., the birthplace of valium. At that time, Jean-Jacques Garaud, head of the Roche unit that Dr. Reed will run, left the company and was replaced on an interim basis by Mike Burgess. Roche said Tuesday that Mr. Burgess would now also leave the company.


Sanford-Burnham said that Dr. Kristiina Vuori, its president and head of its cancer center, would take over as chief executive on an interim basis. Dr. Vuori, who is originally from Finland, has worked closely with Dr. Reed.


M. Wainwright Fishburn Jr., the chairman of Sanford-Burnham, said it was “bittersweet” to see Dr. Reed leave. While the institute will lose a very successful leader, he said, the move could advance the institute’s efforts to get drug discovery work from pharmaceutical companies.


“We have one of our own in one of the most influential positions around,” he said.


Read More..

'Les Miz,' 'Argo' win big at Golden Globes, but Jodie Foster is talk of show









The epic musical “Les Miserables” dominated the 70th annual Golden Globe Awards on Sunday night with three trophies, including one for best musical or comedy. But the evening belonged to Ben Affleck.

Affleck’s political thriller “Argo,” about a CIA plot to rescue Americans trapped in Iran in 1979-80, won for best dramatic film and director for Affleck. It was a bit of vindication, perhaps, for the filmmaker, who was surprisingly absent last week when the Academy of Motion Picture Arts and Sciences announced its Oscar nominations for director.






Since the Oscar snub Thursday, Affleck has not only won a Golden Globe but he also received a Critics’ Choice Movie Award for directing as well.

PHOTOS: Golden Globes 2013 red carpet


“Les Miz” was the most honored film of the ceremony held at the Beverly Hilton Hotel’s International Ballroom and telecast live on NBC. Besides best musical or comedy, it won lead actor for Hugh Jackman, who admitted in his acceptance speech that at one point he almost quit the project after a grueling rehearsal. And Anne Hathaway sang her way to a supporting actress win as the tragic Fantine.

With her pixie haircut and tasteful white gown, Hathaway was reminiscent of a young Audrey Hepburn.

“Thank you for this lovely blunt object,” Hathaway told the Hollywood Foreign Press Assn. “I’ll forever use it as a weapon against self-doubt.”


PHOTOS: Nominees & winners | Red carpet | Best & Worst


The wins for “Les Miz” and “Argo” as well as the two Golden Globes for “Django Unchained” help give those films momentum leading to the Oscars on Feb. 24. But those honors do little to bring clarity to a topsy-turvy awards season that has seen plenty of outstanding movies to choose from — but few clear-cut front-runners.

For example, Steven Spielberg’s “Lincoln” went into the evening with seven Golden Globes nominations — more than any other film. Former President Bill Clinton even appeared to a standing ovation and thunderous applause to introduce the clip for the historical epic. But instead of “Lincoln” by a landslide, the film about the 16th president’s struggle to end the Civil War and slavery won only one honor: lead actor in a drama for Daniel Day-Lewis.

One of the most stunning moments came courtesy Jodie Foster, who took to the stage to give a ... retirement speech? A coming-out speech? It was hard to tell. She was receiving the Cecil B. DeMille Award for lifetime achievement when she ramped up to confess that she was … single. And while she seemed to take pains to sidestep addressing her sexual orientation she did thank her ex-partner and co-parent of her two boys, Cydney Bernard.


PHOTOS: Golden Globes 2013 red carpet

Her speech was also a rant in favor of privacy that brought many people to its feet. Foster noted that she has lived virtually her entire life in the public eye yet wanted to keep some things private. “I have given everything up there from the time I was 3 years old,” she said. “That is reality enough.” Even backstage, talking face-to-face with the media, she was cryptic about what, exactly, she was trying to say with her speech. (Memo to Foster: Nothing will destroy an attempt at privacy like telling the world you want to keep your life private.)

In other film awards, Jessica Chastain won lead actress in a drama for her role as a CIA operative who helps track down Osama bin Laden in “Zero Dark Thirty.” Jennifer Lawrence won lead actress in a comedy or musical for “Silver Linings Playbook” for her performance as a widow in the quirky romantic comedy. “I beat Meryl!” Lawrence joked as she accepted the trophy. (Meryl Streep was nominated in the same category, for “Hope Springs.”) Among Lawrence’s thank-yous: “Thank you, Harvey Weinstein, for killing whoever you had to kill to get me up here.”

Christoph Waltz won for supporting actor for playing a bounty hunter in Quentin Tarantino’s “Django Unchained.” The maverick filmmaker was a surprise screenplay winner for the controversial spaghetti Western set during the slavery era, beating out such favorites as the writers of “Zero Dark Thirty,” “Lincoln,” “Argo,” and “Silver Linings Playbook.”


PHOTOS: Highlights from the show


“Wow, I wasn’t expecting this,” said an effusive Tarantino. “I'm happy to be surprised.”

Austria’s “Amour” won foreign language film, and “Brave” won for animated film. Mychael Danna won for writing the score for Ang Lee’s “Life of Pi.” Original song went to pop singer Adele and Paul Epworth for “Skyfall,” the title tune for the latest James Bond installment.

On the TV side, the Golden Globes honored Showtime’s “Homeland” and HBO’s “Game Change” and "Girls" with multiple trophies.

Golden Globes 2013: List | Red Carpet | Winners | Ballot | Show moments | Quote


“Homeland,” the political thriller that counts President Obama as one of its biggest fans, won its second consecutive award for drama series. Claire Danes won her second-in-a-row Globe for lead dramatic actress in the series. Her co-star Damian Lewis took lead actor.

“Game Change,” the drama about then-Gov. Sarah Palin’s run for the vice presidency in 2008, also performed well. It snapped up three awards: miniseries or TV movie, supporting actor for Ed Harris, and lead actress for Julianne Moore for her uncanny channeling of Palin.

“Girls” won best comedy series while its young star and creator, Lena Dunham, won for lead actress. Don Cheadle won lead actor in a comedy series for Showtime’s “House of Lies.” Kevin Costner won lead actor in a miniseries or TV movie for History Channel’s “Hatfields & McCoys.” Maggie Smith won for supporting actress in a TV series, miniseries or movie for playing the acerbic dowager in PBS' “Downton Abbey.”

After a controversial three-year stint as host, Ricky Gervais turned over the emcee duties to Globe nominees Amy Poehler (“Parks & Recreation”) and Tina Fey (“30 Rock”). The pair were only slightly less irreverent, skewering Hollywood by poking fun of pill-popping Hollywood and “rat-faced” TV types and joking about the controversy surrounding Kathryn Bigelow's “Zero Dark Thirty.”

Cracked Poehler: “When it comes to torture, I trust the woman who spent three years married to James Cameron.”

ALSO:


PHOTOS: Moments from the show


VOTE: Play-at-home Globes ballot


PHOTOS: Red carpet fashion at the Golden Globes


susan.king@latimes.com and rene.lynch@latimes.com






Read More..

A Google-a-Day Puzzle for Jan. 14











Our good friends at Google run a daily puzzle challenge and asked us to help get them out to the geeky masses. Each day’s puzzle will task your googling skills a little more, leading you to Google mastery. Each morning at 12:01 a.m. Eastern time you’ll see a new puzzle posted here.


SPOILER WARNING:
We leave the comments on so people can work together to find the answer. As such, if you want to figure it out all by yourself, DON’T READ THE COMMENTS!


Also, with the knowledge that because others may publish their answers before you do, if you want to be able to search for information without accidentally seeing the answer somewhere, you can use the Google-a-Day site’s search tool, which will automatically filter out published answers, to give you a spoiler-free experience.


And now, without further ado, we give you…


TODAY’S PUZZLE:



Note: Ad-blocking software may prevent display of the puzzle widget.




Ken is a husband and father from the San Francisco Bay Area, where he works as a civil engineer. He also wrote the NYT bestselling book "Geek Dad: Awesomely Geeky Projects for Dads and Kids to Share."

Read more by Ken Denmead

Follow @fitzwillie and @wiredgeekdad on Twitter.



Read More..

French actor Depardieu sides with Putin, criticizes opposition






MOSCOW (Reuters) – French actor Gerard Depardieu, recently awarded Russian citizenship by President Vladimir Putin, has praised the former KGB spy and said his political opponents offer no real alternative.


Depardieu, who has been accused in France of abandoning his homeland to avoid a proposed 75 percent tax for millionaires, told the state-run Rossiya-24 television that Putin personified Russia’s complex and fascinating national character.






“I like this man very much, he is a very powerful political activist. He has political wisdom,” the 63-year-old star of “Cyrano de Bergerac” and “Green Card” said in comments aired late on Sunday, according to the channel’s Russian translation.


The translation was dubbed over the original French, which Rossiya-24 said would not immediately be made available.


Depardieu, who is also due in court to answer charges of crashing his scooter in Paris with more than three times the legal alcohol limit in his blood, said Putin had admitted to liking his “hooligan essence” when the two met in the Russian resort of Sochi last week.


Putin’s opponents accuse him of cracking down on dissent since his return to the presidency for a six-year third term last May. The European Union and the United States have also expressed concern that Moscow is rolling back democratic freedoms.


“The Russian opposition has no program, nothing. There are very smart people there, like (former world chess champion Garry) Kasparov, but what works well for chess is completely unsuited to politics,” Depardieu said.


Opposition activists were quick to react. Violetta Volkova, defense lawyer for several opposition members facing charges over anti-Putin protests, wrote sarcastically on Twitter: “Prominent political analyst Depardieu…”


Putin’s critics have failed to make inroads into his grip on power in over a year of protests sparked by accusations of widespread fraud in parliamentary elections in December 2011, and the presidential vote last March.


The protest movement has gradually lost steam, though tens of thousands of people marched through Moscow on Sunday to protest against a Kremlin-backed law that bans Americans from adopting Russian children.


After the protest, leftist opposition leader Sergei Udaltsov was quoted as inviting Depardieu to take part in the next anti-Putin rallies, given his interest in Russian politics.


Putin says he has developed a friendly personal relationship with Depardieu, a popular figure in Russia, where he has appeared in many advertising campaigns, including for ketchup.


(Reporting by Gabriela Baczynska; Editing by Kevin Liffey)


Movies News Headlines – Yahoo! News





Title Post: French actor Depardieu sides with Putin, criticizes opposition
Url Post: http://www.news.fluser.com/french-actor-depardieu-sides-with-putin-criticizes-opposition/
Link To Post : French actor Depardieu sides with Putin, criticizes opposition
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Susan Nolen-Hoeksema, Psychologist Who Studied Depression in Women, Dies at 53





Susan Nolen-Hoeksema, a psychologist and writer whose work helped explain why women are twice as prone to depression as men and why such low moods can be so hard to shake, died on Jan. 2 in New Haven. She was 53.







Andrew Sacks

Susan Nolen-Hoeksema at the University of Michigan in 2003. Dr. Nolen-Hoeksema's research showed that women were more prone to ruminate, or dwell on the sources of problems rather than solutions, more than men.







Her death followed heart surgery to correct a congenitally weak valve, said her husband, Richard Nolen-Hoeksema.


Dr. Nolen-Hoeksema, a professor at Yale University, began studying depression in the 1980s, a time of great excitement in psychiatry and psychology. New drugs like Prozac were entering the market; novel talking therapies were proving effective, too, particularly cognitive behavior therapy, in which people learn to defuse upsetting thoughts by questioning their basis.


Her studies, first in children and later in adults, exposed one of the most deceptively upsetting of these patterns: rumination, the natural instinct to dwell on the sources of problems rather than their possible solutions. Women were more prone to ruminate than men, the studies found, and in a landmark 1987 paper she argued that this difference accounted for the two-to-one ratio of depressed women to depressed men.


She later linked rumination to a variety of mood and behavior problems, including anxiety, eating disorders and substance abuse.


“The way I think she’d put it is that, when bad things happen, women brood — they’re cerebral, which can feed into the depression,” said Martin Seligman, a professor of psychology at the University of Pennsylvania, who oversaw her doctoral work. “Men are more inclined to act, to do something, plan, beat someone up, play basketball.”


Dr. Seligman added, “She was the leading figure in sex differences in depression of her generation.”


Dr. Nolen-Hoeksema wrote several books about her research for general readers, including “Women Who Think Too Much: How to Break Free of Overthinking and Reclaim Your Life.” These books described why rumination could be so corrosive — it is deeply distracting; it tends to highlight negative memories — and how such thoughts could be alleviated.


Susan Kay Nolen was born on May 22, 1959, in Springfield, Ill., to John and Catherine Nolen. Her father ran a construction business, where her mother was the office manager; Susan was the eldest of three children.


She entered Illinois State University before transferring to Yale. She graduated summa cum laude in 1982 with a degree in psychology.


After earning a Ph.D. in psychology at the University of Pennsylvania, she joined the faculty at Stanford. She later moved to the University of Michigan, before returning to Yale in 2004.


Along the way she published scores of studies and a popular textbook. In 2003 she became the editor of the Annual Review of Clinical Psychology, an influential journal.


Dr. Nolen-Hoeksema moved smoothly between academic work and articles and books for the general reader.


“I think part of what allowed her to move so easily between those two worlds was that she was an extremely clear thinker, and an extremely clear writer,” said Marcia K. Johnson, a psychology professor and colleague at Yale.


Dr. Nolen-Hoeksema lived in Bethany, Conn. In addition to her husband, a science writer, she is survived by a son, Michael; her brothers, Jeff and Steve; and her father, John.


“Over the past four decades women have experienced unprecedented growth in independence and opportunities,” Dr. Nolen-Hoeksema wrote in 2003, adding, “We have many reasons to be happy and confident.”


“Yet when there is any pause in our daily activities,” she continued, “many of us are flooded with worries, thoughts and emotions that swirl out of control, sucking our emotions and energy down, down, down. We are suffering from an epidemic of overthinking.”


Read More..

Wheels Blog: The Seventh-Generation Corvette Is Unveiled in Detroit

DETROIT — The Stingray is back, in name and in spirit.

At an invitation-only gathering hours before the North American International Auto Show was scheduled to open for press previews, General Motors introduced the 2014 Corvette, the seventh generation of Chevrolet’s hallmark sports car.

Underscoring the importance of this vehicle was Chevrolet’s revival of the long-dormant Stingray badge, a name it first used on a 1959 racecar built by G.M.’s design chief, Bill Mitchell. The hope for that original Stingray racecar was to beat Europe’s best, and G.M. still seems to be thinking along those lines.

According to G.M.’s president for North America, Mark Reuss, the latest Stingray is a potential worldbeater.

“Like the ’63 Sting Ray, the best Corvettes embodied performance leadership, delivering cutting-edge technologies, breathtaking design and awe-inspiring driving experiences,” Mr. Reuss said. “The all-new Corvette goes farther than ever, thanks to today’s advancements in design technology and engineering.”

The release of a new Corvette is always highly anticipated by auto enthusiasts; speculation about “C7″ — shorthand for the seventh generation — has run high. Would it get a twin-cam turbocharged powertrain? Would Chevy switch to an exotic midengine chassis?

In actuality, the 2014 model will again have a pushrod V-8 engine in its nose, driving the rear wheels. That conservative approach might be seen as a timid compromise from a company that has just begun to get back on solid financial footing. But the front-engine, rear-drive layout has long defined the Corvette, and this car, like its C6 predecessor, may well show its taillights to cars with specs that more closely conform to what is considered state of the art.

While automakers are quick to toss around the words “all new” to describe their latest offerings, however warmed over they might be, in this case the term is justified — the 2014 Corvette shares only two parts with its predecessor.

The C7 Corvette’s styling is in keeping with the brand’s persona, yet it projects a more aggressive image than previous generations. The clean front fascia is devoid of parking lights, and is energized by a sharp edge where it meets the hood, which is itself defined by a prominent bulge and more hard edges. The curve of the front fenders peaks at yet another edge that blends seamlessly into the body side at the A-pillar. The body’s flanks are defined by character lines that race back from vents behind the front wheel, not unlike those of previous Corvettes, but here those lines are more sharply drawn, with the upper line sweeping up and back to define the shape of the rear quarter panel. The lower character line projects from the body, forming a wing of sorts that flows out of the front fender and terminates at the rear of the door. The coupe’s roofline arcs smoothly to meet the rear spoiler, rather than terminating at the rear window, as in the C6. The individual rear taillights that have long been a part of Corvette design are now paired in a deep recess on each side. Four large exhaust pipes exit center-stage, rear.

The sheet-molded fiberglass body, with carbon-fiber hood and roof panels and carbon-nano composite underbody panels, is 37 pounds lighter than the C6’s body. It rides on a new aluminum frame that is 57 percent stiffer and 99 pounds lighter than the current model’s. The wheelbase is about one inch longer than that of the C6, and the track is almost an inch wider — changes said to provide a more stable feel at high speed.

Inside the cockpit, considerable effort was lavished on upgrading what has generally been considered a blighted zone. Optional carbon fiber trim and real aluminum combine with plastic in a wraparound configuration. The steering wheel, with a 14.1 inch diameter, is smaller than that of the previous model, and two seat choices are offered, with the competition sport version providing more side bolstering to hold occupants in place in spirited maneuvers. Indicative of the car’s purpose is the inclusion of a console-mounted steel grab bar for the passenger.

Under the hood, Chevrolet’s 6.2-liter small block V-8 — now in its fifth-generation design — produces an estimated 450 horsepower and 450 pound-feet of torque. At low speed, torque output exceeds that of the previous 6.2-liter engine by 50 pound-feet. The engine shares few parts with prior Corvette V-8s and is fitted with direct fuel injection that, in combination with other refinements, enables a high compression ratio of 11.5:1. Active Fuel Management, G.M.’s system for deactivating cylinders when they are not needed, lets the car cruise on four cylinders in some driving modes. Final fuel-economy numbers are not yet available.

Two transaxles will be offered: a 6-speed automatic with paddle-shift mode or a 7-speed manual with rev-matching capability — an electronic version of the heel-and-toe shifting techniques that competition drivers employ to enable smooth gear changes when negotiating twisty bits.

The Corvette driver will be able to select from among five driving modes: weather, Eco, Tour, Sport and Track; the default setting will be Tour. Changing modes alters 12 vehicle attributes, including throttle response, shift points, engagement of the limited-slip differential engagement, shock damping and more. Four-piston Brembo brakes provide stopping power, and electric power steering sets the course.

An optional Z51 performance package adds an electronic limited-slip differential that can continuously vary torque split between the rear wheels, dry-sump oiling, upgraded shock absorbers, a revised version of the automaker’s Magnetic Ride Control suspension-regulating system, close-ratio gears for the manual transmission, larger brake rotors and aerodynamic refinements that incorporate air-flow management for cooling of heat-stressed components.

Like its predecessor, the 2014 Corvette Stingray will be built at a G.M. plant in Bowling Green, Ky. The car is expected to arrive at dealerships in the third quarter of this year.

Read More..